Unbalanced Randomization Influences Placebo Response: Scientific Versus Ethical Issues Around the Use of Placebo in Migraine Trials
- 1 October 1999
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 19 (8) , 699-700
- https://doi.org/10.1046/j.1468-2982.1999.019008699.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Zolmitriptan, a 5‐HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose‐range finding studyEuropean Journal of Neurology, 1998
- Efficacy and Adverse Events of Subcutaneous, Oral, and Intranasal Sumatriptan Used for Migraine Treatment: A Systematic Review Based on Number Needed To TreatCephalalgia, 1998
- Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraineNeurology, 1997
- Optimizing the dose of zolmitriptan (Zomig,* 311C90) for the acute treatment of migraineNeurology, 1997
- 311C90: Increasing the options for therapy with effective acute antimigraine 5HT 1B/1D receptor agonistsNeurology, 1997
- Guidelines for Controlled Trials of Drugs in Migraine. First EditionCephalalgia, 1991